- Home
- CISO vs BGLC Comparison
CISO vs BGLC Comparison
Compare CISO & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- BGLC
- Stock Information
- Founded
- CISO 2015
- BGLC 2017
- Country
- CISO United States
- BGLC Malaysia
- Employees
- CISO N/A
- BGLC N/A
- Industry
- CISO Computer Software: Prepackaged Software
- BGLC Medical Specialities
- Sector
- CISO Technology
- BGLC Health Care
- Exchange
- CISO Nasdaq
- BGLC Nasdaq
- Market Cap
- CISO 8.3M
- BGLC 7.6M
- IPO Year
- CISO N/A
- BGLC N/A
- Fundamental
- Price
- CISO $0.88
- BGLC $0.37
- Analyst Decision
- CISO
- BGLC
- Analyst Count
- CISO 0
- BGLC 0
- Target Price
- CISO N/A
- BGLC N/A
- AVG Volume (30 Days)
- CISO 99.5K
- BGLC 117.9K
- Earning Date
- CISO 11-11-2024
- BGLC 11-20-2024
- Dividend Yield
- CISO N/A
- BGLC N/A
- EPS Growth
- CISO N/A
- BGLC N/A
- EPS
- CISO N/A
- BGLC N/A
- Revenue
- CISO $55,807,138.00
- BGLC $9,183,168.00
- Revenue This Year
- CISO $78.76
- BGLC N/A
- Revenue Next Year
- CISO N/A
- BGLC N/A
- P/E Ratio
- CISO N/A
- BGLC N/A
- Revenue Growth
- CISO 29.55
- BGLC N/A
- 52 Week Low
- CISO $0.26
- BGLC $0.31
- 52 Week High
- CISO $3.60
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- CISO 57.14
- BGLC 32.80
- Support Level
- CISO $0.77
- BGLC $0.38
- Resistance Level
- CISO $1.08
- BGLC $0.49
- Average True Range (ATR)
- CISO 0.12
- BGLC 0.02
- MACD
- CISO -0.01
- BGLC -0.01
- Stochastic Oscillator
- CISO 53.55
- BGLC 5.94
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.